Non-polio enteroviruses affect millions of people worldwide each year, and are often found in the respiratory secretions (e.g., saliva, sputum, or nasal mucus) and stool of an infected person. An epidemiological survey of non-polio enterovirus among families in Mongolia was conducted in the late summer of 2003. In an epidemiological survey of NPEV and HPeV types detected from stool and cerebrospinal fluid (CSF) samples from patients admitted to hospital in the period from 2007 through 2011 in Amsterdam, a total of 570 patients were found positive for a NPEV (n=339), HPeV (n=196), or both (n=35) by real-time RT-PCR in stool and/or CSF as described previously.
Supportive treatments include measures to improve breathing capacity, ranging from oxygen therapy to inhaled steroids to ventilator support. Other medications that may be prescribed include pain-control medications and medications to reduce fever. The vast majority of cases of non-polio enterovirus infection do not cause symptoms or cause mild illness with an excellent prognosis